Related references
Note: Only part of the references are listed.In vivo synaptic density relates to glucose metabolism at rest in healthy subjects, but is strongly modulated by regional differences
June van Aalst et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2021)
Comparison of [11C]UCB-J and [18F]FDG PET in Alzheimer's disease: A tracer kinetic modeling study
Ming-Kai Chen et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2021)
Synaptic density in healthy human aging is not influenced by age or sex: a 11C-UCB-J PET study
Laura Michiels et al.
NEUROIMAGE (2021)
PET molecular imaging of phosphodiesterase 10A: An early biomarker of Huntington's disease progression
Patrik Fazio et al.
MOVEMENT DISORDERS (2020)
Loss of Presynaptic Terminal Integrity in the Substantia Nigra in Early Parkinson's Disease
Aline Delva et al.
MOVEMENT DISORDERS (2020)
Quantifying SV2A density and drug occupancy in the human brain using [11C]UCB-J PET imaging and subcortical white matter as reference tissue
Michel Koole et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Axonal transport: Driving synaptic function
Pedro Guedes-Dias et al.
SCIENCE (2019)
Selection of Reference Regions to Model Neurodegeneration in Huntington Disease by 18F-FDG PET/CT Using Imaging and Clinical Parameters
Diego Alfonso Lopez Mora et al.
CLINICAL NUCLEAR MEDICINE (2019)
[18F]FDG PET signal is driven by astroglial glutamate transport
Eduardo R. Zimmer et al.
NATURE NEUROSCIENCE (2017)
Glucose utilization: still in the synapse
A. Jon Stoessl
NATURE NEUROSCIENCE (2017)
Striatal Local Circuitry: A New Framework for Lateral Inhibition
Dennis A. Burke et al.
NEURON (2017)
Molecular imaging Markers to Track Huntington's Disease Pathology
Heather Wilson et al.
FRONTIERS IN NEUROLOGY (2017)
Huntington's disease (HD): the neuropathology of a multisystem neurodegenerative disorder of the human brain
U. Rueb et al.
BRAIN PATHOLOGY (2016)
Glucose consumption of inflammatory cells masks metabolic deficits in the brain
Heiko Backes et al.
NEUROIMAGE (2016)
Imaging synaptic density in the living human brain
Sjoerd J. Finnema et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Abnormal cerebellar volume and corticocerebellar dysfunction in early manifest Huntington's disease
Robert Christian Wolf et al.
JOURNAL OF NEUROLOGY (2015)
Huntington disease
Gillian P. Bates et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Progressive axonal transport and synaptic protein changes correlate with behavioral and neuropathological abnormalities in the heterozygous Q175 KI mouse model of Huntington's disease
Gaynor A. Smith et al.
HUMAN MOLECULAR GENETICS (2014)
Huntington disease: natural history, biomarkers and prospects for therapeutics
Christopher A. Ross et al.
NATURE REVIEWS NEUROLOGY (2014)
Differential loss of thalamostriatal and corticostriatal input to striatal projection neuron types prior to overt motor symptoms in the Q140 knock-in mouse model of Huntington's disease
Yun-Ping Deng et al.
FRONTIERS IN SYSTEMS NEUROSCIENCE (2014)
Degeneration of the Cerebellum in Huntington's Disease (HD): Possible Relevance for the Clinical Picture and Potential Gateway to Pathological Mechanisms of the Disease Process
Udo Rueb et al.
BRAIN PATHOLOGY (2013)
Loss of corticostriatal and thalamostriatal synaptic terminals precedes striatal projection neuron pathology in heterozygous Q140 Huntington's disease mice
Y. P. Deng et al.
NEUROBIOLOGY OF DISEASE (2013)
Impaired cortico-striatal functional connectivity in prodromal Huntington's Disease
Paul G. Unschuld et al.
NEUROSCIENCE LETTERS (2012)
The importance of appropriate partial volume correction for PET quantification in Alzheimer's disease
Benjamin A. Thomas et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Widespread Decrease of Type 1 Cannabinoid Receptor Availability in Huntington Disease In Vivo
Koen Van Laere et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Basal ganglia volume and clinical correlates in 'preclinical' Huntington's disease
Caroline K. Jurgens et al.
JOURNAL OF NEUROLOGY (2008)
Role of brain-derived neurotrophic factor in Huntington's disease
Chiara Zuccato et al.
PROGRESS IN NEUROBIOLOGY (2007)
Microglial activation correlates with severity in Huntington disease - A clinical and PET study
N. Pavese et al.
NEUROLOGY (2006)
Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor
ZC Baquet et al.
JOURNAL OF NEUROSCIENCE (2004)
In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease
C Fennema-Notestine et al.
NEUROLOGY (2004)
Early changes in Huntington's disease patient brains involve alterations in cytoskeletal and synaptic elements
NA DiProspero et al.
JOURNAL OF NEUROCYTOLOGY (2004)
Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport
G Szebenyi et al.
NEURON (2003)
Evidence for more widespread cerebral pathology in early HD - An MRI-based morphometric analysis
HD Rosas et al.
NEUROLOGY (2003)
Resting-state brain glucose utilization as measured by PET is directly related to regional synaptophysin levels: a study in baboons
AB Rocher et al.
NEUROIMAGE (2003)
Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain
N Tzourio-Mazoyer et al.
NEUROIMAGE (2002)
Share Paper
